GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Lab] 12th independent test on SGN — 98.1% on a claimed 98.0%, and the trend is the interesting part — 33 comments in the full submission. View in context.
828
c/bpc157·submitted 5 months ago by u/mariam_cabrera

[Lab] 12th independent test on SGN — 98.1% on a claimed 98.0%, and the trend is the interesting part

Labbranch of 7 comments

Result first, context after: 12th independent test on SGN — 98.1% on a claimed 98.0%, and the trend is the interesting part . Everything below is how it was ordered, stored and sent. Pulling the figures out of the title: 98.1% and 98.0%. All of it is written down as it happened rather than reconstructed. Every claim…

Read the full submission and all 33 comments →

This branch

7 comments, started 5 months ago
u/vikram_mbeki43 points·5 months ago

Agreed — cheap to make is a double-edged fact and it explains a lot about this corner of the market.

replysharereportpermalink
u/mariam_cabreraOP34 points·5 months ago

pentadecapeptide, fifteen residues, and the sequence is public

replysharereportpermalink
u/fatima_wojcik11 points·5 months ago

a fifteen-residue peptide is easy to make and easy to make badly

replysharereportpermalink
u/milos_mensa16 points·5 months ago

Went and read the primary rodent papers after arguing about a summary for a week. They are much narrower than the threads suggest.

replysharereportpermalink
u/joaquin_ivaturi12 points·5 months ago

regulatory status varies by jurisdiction and it has moved recently

replysharereportpermalink
u/marit_sandvik14 points·5 months ago

ask for the mass spectrum, not just the purity number

replysharereportpermalink
u/honest_syringe2430 points·5 months ago

Agreed — cheap to make is a double-edged fact and it explains a lot about this corner of the market.

Disagreeing with this line: that paper is in a rodent model and it is being quoted as a human result.

replysharereportpermalink

← back to the whole thread

About c/bpc157

BPC-157 as it actually is: a pentadecapeptide with a genuinely interesting rodent tendon-and-gut literature, near-zero controlled human data, a naming and sequence mess in the supply chain, and a regulatory status that changed sharply in several countries.

35kmembers
62submissions
Mar 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/bpc157 rules
  1. Research use only. No human protocols, no injection instructions.
  2. Rodent data must be labelled as rodent data in the body.
  3. Sequence and naming claims need the actual sequence.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.